These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries]. Burow W; Lüllmann H Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578 [No Abstract] [Full Text] [Related]
3. [Pharmacology--basis of drug testing by the physician]. Herken H Internist (Berl); 1973 Jan; 14(1):6-13. PubMed ID: 4576797 [No Abstract] [Full Text] [Related]
4. [Responsibility for drug testing and control]. Büchi J Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866 [No Abstract] [Full Text] [Related]
5. [Standardization as a basis planning and administration in drug industry and pharmacy (II)]. Wagler M Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874 [No Abstract] [Full Text] [Related]
7. [Is openness in the drug market possible?]. Dölle W; Schwabe U Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513 [No Abstract] [Full Text] [Related]
8. [Drugs]. Greppin R Z Krankenpfl; 1972 Dec; 65(12):446-51. PubMed ID: 4486551 [No Abstract] [Full Text] [Related]
9. [Standards imposed by the pharmacopoeia on drugs]. Büchi J Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534 [No Abstract] [Full Text] [Related]
10. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573 [TBL] [Abstract][Full Text] [Related]
11. 3. Drug regulations in Switzerland and their application. Hippenmeier F Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448 [No Abstract] [Full Text] [Related]
12. [Course and problems of clinical drug testing]. Neuhaus GA Internist (Berl); 1973 Jan; 14(1):14-8. PubMed ID: 4576791 [No Abstract] [Full Text] [Related]
13. GMPs vs GCPs: United States Pharmacopeia General Chapters. Allen LV Int J Pharm Compd; 2013; 17(5):439. PubMed ID: 24459791 [No Abstract] [Full Text] [Related]
14. [What should a medical health officer know about the law regulations concerning pharmacists]. Aye E Offentl Gesundheitswes; 1969 Oct; 31(10):477-98. PubMed ID: 4252924 [No Abstract] [Full Text] [Related]
15. [The doctor's responsibility and risk in the prescribing of drugs]. Aschenbrenner R Munch Med Wochenschr; 1973 Apr; 115(17):741-6. PubMed ID: 4574431 [No Abstract] [Full Text] [Related]
16. [Detection of side effects. 2: Responsibilities of the pharmaceutical industry, drug commissions, the Federal Health Office and international organizations]. Gleiter CH; Bieck PR Fortschr Med; 1991 Jul; 109(21):429-31. PubMed ID: 1916572 [No Abstract] [Full Text] [Related]
17. WHO Expert Committee on Specifications for Pharmaceutical Preparations. 22. World Health Organ Tech Rep Ser; 1969; 418():1-29. PubMed ID: 4980004 [No Abstract] [Full Text] [Related]
18. [Clinical testing of drugs]. Begemann H Med Klin; 1973 May; 68(18):569-71. PubMed ID: 4576603 [No Abstract] [Full Text] [Related]
19. USP and the Drug Regulation Reform Act. Heller WM J Parenter Drug Assoc; 1979; 33(2):55-60. PubMed ID: 255147 [No Abstract] [Full Text] [Related]
20. [Is the testing of drugs satisfactory?]. Kohlhaas M Munch Med Wochenschr; 1970 Dec; 112(49):2224-6. PubMed ID: 5536811 [No Abstract] [Full Text] [Related] [Next] [New Search]